Bellafill® is the only long-term filler that's FDA approved to treat distensible acne scars for up to one year.
All rights and credit go directly to its rightful owner. No copyright infringement intended, AHQ does not own this video.
An ideal candidate for Bellafill is a healthy individual over 21 years of age with atrophic acne scars.
Minimal downtime: Bellafill injections typically require minimal downtime, allowing patients to resume their daily activities shortly after the procedure.
The majority of individuals notice about a 50-60% reduction in acne scarring approximately six weeks after their initial treatment, and results can continue to improve for up to a year.